Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Enterprise value to sales ratio
3Y CAGR
+0.8%/yr
Annual compound
Percentile
P89
Within normal range
vs 3Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.29 | +46.4% |
| 2024 | 2.93 | -30.2% |
| 2023 | 4.19 | +0.1% |
| 2022 | 4.19 | -76.6% |
| 2021 | 17.92 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |